Stockscreener 앱 받기
5.50
3.51%
-0.20
시장 영업 전:
5.50
Protara Therapeutics Inc 주식(TARA)의 최신 뉴스
Protara Therapeutics Raises $86.3 Million in Offering - TipRanks
Acorn Capital Advisors LLC Acquires 472,315 Shares of Protara Therapeutics, Inc. $TARA - MarketBeat
Protara Therapeutics, Inc. $TARA is Velan Capital Investment Management LP's 4th Largest Position - MarketBeat
Protara Therapeutics completes $75 million stock offering - MSN
Protara Therapeutics Completes $75 Million Stock Offering - TipRanks
Protara therapeutics raises $75 million in public offering - Investing.com
Protara Therapeutics Closes $75 Million Public Offering - marketscreener.com
Protara therapeutics raises $75 million in public offering By Investing.com - Investing.com India
Protara Announces Closing of $75 Million Public Offering - The Manila Times
Protara Therapeutics (Nasdaq: TARA) closes $75M stock sale of 13.0M shares at $5.75 - Stock Titan
Protara Therapeutics slumps 12%, raises $75M equity at $5.75 per share - MSN
Protara announces proposed public offering - MSN
Is Protara Therapeutics Inc a good long term investmentOptions Trading Strategies & High Return Trading Strategies - earlytimes.in
Protara Therapeutics Inc. (TARA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Protara Therapeutics: Stock Offer Takes the Spotlight - StocksToTrade
Protara Therapeutics (TARA) Stock Plunges After $75 Million Offering: Latest Trial Data, Analyst Targets and Outlook as of December 5, 2025 - ts2.tech
Protara Prices $75 Mln Offering To Advance TARA-002 And Broader Pipeline - Nasdaq
Biotech co Protara slides on $75 mln share sale - TradingView — Track All Markets
Protara Therapeutics Shares Sink 16% After $75 Mln Public Offering - Nasdaq
Protara Therapeutics (Nasdaq: TARA) prices 13,043,479-share, $75M public deal - Stock Titan
Protara Therapeutics (TARA) Launches $75M Public Offering - GuruFocus
Protara Therapeutics Prices $75 Million Share Offering - marketscreener.com
Will Protara Therapeutics Inc. (1KPA) stock benefit from sector leadershipJuly 2025 Price Swings & Accurate Trade Setup Notifications - Newser
Protara Therapeutics prices $75 million public offering By Investing.com - Investing.com Nigeria
TARA Stock Offering Priced at Lower End of Target Range - GuruFocus
Protara Therapeutics prices $75 million public offering - Investing.com
Key Managers Announced for TARA Offering - GuruFocus
Protara Announces Pricing of $75 Million Public Offering - The Manila Times
Protara prices public offering of 13.04 million shares at $5.75 each - marketscreener.com
Protara Announces Pricing of $75 Million Public Offering - GlobeNewswire Inc.
Protara Therapeutics stock tumbles after $75M public offering By Investing.com - Investing.com Australia
Protara Therapeutics Launches Offering of Securities - marketscreener.com
Protara Therapeutics announces $75 million public offering - Investing.com
Protara Therapeutics stock tumbles after $75M public offering - Investing.com
Protara Therapeutics announces $75 million public offering By Investing.com - Investing.com South Africa
Protara Announces Proposed Public Offering - The Manila Times
Protara Therapeutics Announces $75 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Protara Therapeutics (Nasdaq: TARA) starts $75M stock and pre-funded warrant sale - Stock Titan
Protara Therapeutics (NASDAQ:TARA) Receives "Buy" Rating from HC Wainwright - MarketBeat
Protara’s cell therapy touts BCG-naïve treatment potential in Phase II - Yahoo Finance
Protara Therapeutics Announces Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naive NMIBC Patients - marketscreener.com
Protara Therapeutics: End Of 2025 Proving Eventful Indeed (NASDAQ:TARA) - Seeking Alpha
Why Protara Therapeutics Inc. (1KPA) stock is listed among top recommendationsEarnings Overview Report & Daily Stock Trend Reports - Newser
Protara Therapeutics (NASDAQ:TARA) Receives Buy Rating from HC Wainwright - Defense World
0.36%
1.05%
자본화:
|
볼륨(24시간):